GRDN shows strong operational improvement with substantially higher operating cash flows and meaningful SG&A expense reduction, while maintaining solid revenue growth.
The company demonstrates improving operational efficiency as evidenced by the substantial cash flow improvement alongside reduced SG&A expenses, suggesting management's cost control initiatives are taking hold. The revenue growth of nearly 18% combined with expanding margins indicates GRDN is successfully scaling its long-term care pharmacy operations while optimizing its cost structure.
GRDN delivered strong financial performance with revenue growing nearly 18% to $1.4B and gross profit expanding 20% to $293M, while SG&A expenses declined meaningfully by 28% to $220M. Operating cash flow substantially improved, reflecting enhanced operational efficiency and better working capital management. The balance sheet strengthened with total assets growing 29% and stockholders' equity expanding 45%, indicating solid capital accumulation and financial health as the company scales its pharmacy network serving over 205,000 residents across 38 states.
Operating cash flow surged 73% — exceptional cash generation, highest quality earnings signal.
Current assets grew 45.8% — improving short-term liquidity or inventory/receivables build.
Equity base grew 45.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Asset base grew 28.6% — expansion through organic growth, acquisitions, or capital deployment.
SG&A reduced 28.4% — improved cost efficiency or headcount reduction improving operating margins.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Revenue growing 17.9% — solid top-line momentum, watch margins for quality of growth.
Liabilities increased 14% — monitor debt-to-equity ratio and interest coverage.
Current liabilities rose 11.5% — increased short-term obligations, watch current ratio.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →